New registry tracks blood thinner safety in rare clotting disorder
NCT ID NCT04262492
First seen May 14, 2026 · Last updated May 17, 2026 · Updated 1 time
Summary
This study is creating a registry to collect information on antiphospholipid syndrome (APS) patients who are taking direct oral anticoagulants (DOACs). Researchers will track about 500 adults to see how often blood clots or bleeding occur. The goal is to better understand the safety and effectiveness of these medications in this specific group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stéphane Zuily
RECRUITINGNancy, 54500, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.